Forms of CDDO methyl ester
A triterpenoid compound, methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate (CDDO methyl ester), has a non-crystalline, glassy solid form and a non-hydrous crystalline form that can prepared, for example, from a saturated methanol solution. The glassy form displays an enhanced bioavailability over the non-hydrous crystalline form. Each form of CDDO methyl ester is a superior candidate for use, typically in solid dosage form, for treating a variety of disease states, generally associated with inflammation.
1. A solid form of methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate (CDDO-methyl ester) prepared by a process comprising the step of cryogrinding anhydrous, crystalline CDDO-methyl ester that is characterized by its X-ray powder diffractogram comprising peaks at 8.78°2θ, 12.94°2θ, 13.35°2θ, 14.18°2θ, and 17.4°2θ±0.2°2θ based upon data collected on a diffractometer with Cu K α , radiation.